{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:50:11Z","timestamp":1773211811974,"version":"3.50.1"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b17-00479","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T22:16:16Z","timestamp":1512080176000},"page":"2134-2139","source":"Crossref","is-referenced-by-count":13,"title":["Active Ingredients of Hange-shashin-to, Baicalelin and 6-Gingerol, Inhibit 5-Fluorouracil-Induced Upregulation of CXCL1 in the Colon to Attenuate Diarrhea Development"],"prefix":"10.1248","volume":"40","author":[{"given":"Hiroyasu","family":"Sakai","sequence":"first","affiliation":[{"name":"Department of Analytical Pathophysiology, Division of Pharmacy Professional Development and Research, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Tabata","sequence":"additional","affiliation":[{"name":"Department of Analytical Pathophysiology, Division of Pharmacy Professional Development and Research, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minami","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Analytical Pathophysiology, Division of Pharmacy Professional Development and Research, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Yabe","sequence":"additional","affiliation":[{"name":"Department of Analytical Pathophysiology, Division of Pharmacy Professional Development and Research, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Isa","sequence":"additional","affiliation":[{"name":"Department of Analytical Pathophysiology, Division of Pharmacy Professional Development and Research, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kai","sequence":"additional","affiliation":[{"name":"Department of Analytical Pathophysiology, Division of Pharmacy Professional Development and Research, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Analytical Pathophysiology, Division of Pharmacy Professional Development and Research, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Yumoto","sequence":"additional","affiliation":[{"name":"Department of Analytical Pathophysiology, Division of Pharmacy Professional Development and Research, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Miyano","sequence":"additional","affiliation":[{"name":"Division of Cancer Pathophysiology, National Cancer Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Uezono","sequence":"additional","affiliation":[{"name":"Division of Cancer Pathophysiology, National Cancer Center Research Institute"},{"name":"Division of Supportive Cancer Research, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center"},{"name":"Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Klopp AH, Zhang Y, Solley T, Amaya-Manzanares F, Marini F, Andreeff M, Debeb B, Woodward W, Schmandt R, Broaddus R, Lu K, Kolonin MG. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin. Cancer Res.<\/i>, 18<\/b>, 771\u2013782 (2012).","DOI":"10.1158\/1078-0432.CCR-11-1916"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol.<\/i>, 56<\/b>, 559\u2013564 (1994).","DOI":"10.1002\/jlb.56.5.559"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Modi WS, Yoshimura T. Isolation of novel GRO genes and a phylogenetic analysis of the CXC chemokine subfamily in mammals. Mol. Biol. Evol.<\/i>, 16<\/b>, 180\u2013193 (1999).","DOI":"10.1093\/oxfordjournals.molbev.a026101"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Chintakuntlawar AV, Chodosh J. Chemokine CXCL1\/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis. J. Interferon Cytokine Res.<\/i>, 29<\/b>, 657\u2013666 (2009).","DOI":"10.1089\/jir.2009.0006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ritzman AM, Hughes-Hanks JM, Blaho VA, Wax LE, Mitchell WJ, Brown CR. The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis. Infect. Immun.<\/i>, 78<\/b>, 4593\u20134600 (2010).","DOI":"10.1128\/IAI.00798-10"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sakai H, Sagara A, Matsumoto K, Jo A, Hirosaki A, Takase K, Sugiyama R, Sato K, Ikegami D, Horie S, Matoba M, Narita M. Neutrophil recruitment is critical for 5-fluorouracil-induced diarrhea and the decrease in aquaporins in the colon. Pharmacol. Res.<\/i>, 87<\/b>, 71\u201379 (2014).","DOI":"10.1016\/j.phrs.2014.05.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sakai H, Kai Y, Oguchi A, Kimura M, Tabata S, Yaegashi M, Saito T, Sato K, Sato F, Yumoto T, Narita M. Curcumin inhibits 5-fluorouracil-induced up-regulation of CXCL1 and CXCL2 of the colon associated with attenuation of diarrhoea development. Basic Clin. Pharmacol. Toxicol.<\/i>, 119<\/b>, 540\u2013547 (2016).","DOI":"10.1111\/bcpt.12619"},{"key":"8","unstructured":"8) Stein A, Voigt W, Jordan K. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther. Adv. Med. Oncol.<\/i>, 2<\/b>, 51\u201363 (2010)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kase Y, Hayakawa T, Takeda S, Ishige A, Aburada M, Okada M. Pharmacological studies on antidiarrheal effects of hange-shashin-to. Biol. Pharm. Bull.<\/i>, 19<\/b>, 1367\u20131370 (1996).","DOI":"10.1248\/bpb.19.1367"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kase Y, Saitoh K, Ishige A, Komatsu Y. Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levels. Biol. Pharm. Bull.<\/i>, 21<\/b>, 1277\u20131281 (1998).","DOI":"10.1248\/bpb.21.1277"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kase Y, Yuzurihara M, Iizuka S, Ishige A, Komatsu Y. The effects of hange-shashin-to on gastric function in comparison with sho-saiko-to. Biol. Pharm. Bull.<\/i>, 20<\/b>, 1155\u20131159 (1997).","DOI":"10.1248\/bpb.20.1155"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Lixuan Z, Jingcheng D, Wenqin Y, Jianhua H, Baojun L, Xiaotao F. Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models. Pulm. Pharmacol. Ther.<\/i>, 23<\/b>, 411\u2013419 (2010).","DOI":"10.1016\/j.pupt.2010.05.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Li Z, Zheng J, Zhang N, Li C. Berberine improves airway inflammation and inhibits NF-kappaB signaling pathway in an ovalbumin-induced rat model of asthma. J. Asthma<\/i>, 53<\/b>, 999\u20131005 (2016).","DOI":"10.1080\/02770903.2016.1180530"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Lee TY, Lee KC, Chen SY, Chang HH. 6-Gingerol inhibits ROS and iNOS through the suppression of PKC-alpha and NF-kappaB pathways in lipopolysaccharide-stimulated mouse macrophages. Biochem. Biophys. Res. Commun.<\/i>, 382<\/b>, 134\u2013139 (2009).","DOI":"10.1016\/j.bbrc.2009.02.160"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sakai H, Sagara A, Matsumoto K, Hasegawa S, Sato K, Nishizaki M, Shoji T, Horie S, Nakagawa T, Tokuyama S, Narita M. 5-Fluorouracil induces diarrhea with changes in the expression of inflammatory cytokines and aquaporins in mouse intestines. PLOS ONE<\/i>, 8<\/b>, e54788 (2013).","DOI":"10.1371\/journal.pone.0054788"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kono T, Kaneko A, Matsumoto C, Miyagi C, Ohbuchi K, Mizuhara Y, Miyano K, Uezono Y. Multitargeted effects of hange-shashin-to for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin E2 production in human oral keratinocytes. Integr. Cancer Ther.<\/i>, 13<\/b>, 435\u2013445 (2014).","DOI":"10.1177\/1534735413520035"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Burke SJ, Lu D, Sparer TE, Masi T, Goff MR, Karlstad MD, Collier JJ. NF-\u03baB and STAT1 control CXCL1 and CXCL2 gene transcription. Am. J. Physiol. Endocrinol. Metab.<\/i>, 306<\/b>, E131\u2013E149 (2014).","DOI":"10.1152\/ajpendo.00347.2013"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nguyen DP, Li J, Yadav SS, Tewari AK. Recent insights into NF-kappaB signalling pathways and the link between inflammation and prostate cancer. BJU Int.<\/i>, 114<\/b>, 168\u2013176 (2014).","DOI":"10.1111\/bju.12488"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Shieh JM, Tsai YJ, Tsou CJ, Wu WB. CXCL1 regulation in human pulmonary epithelial cells by tumor necrosis factor. Cell. Physiol. Biochem.<\/i>, 34<\/b>, 1373\u20131384 (2014).","DOI":"10.1159\/000366344"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Miyake M, Goodison S, Urquidi V, Gomes Giacoia E, Rosser CJ. Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1\/2 and EGF pathways. Lab. Invest.<\/i>, 93<\/b>, 768\u2013778 (2013).","DOI":"10.1038\/labinvest.2013.71"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, Gunzer M, Roers A, Hogg N. Mast cell and macrophage chemokines CXCL1\/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood<\/i>, 121<\/b>, 4930\u20134937 (2013).","DOI":"10.1182\/blood-2013-02-486217"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kase Y, Hayakawa T, Ishige A, Aburada M, Komatsu Y. The effects of hange-shashin-to on the content of prostaglandin E2 and water absorption in the large intestine of rats. Biol. Pharm. Bull.<\/i>, 20<\/b>, 954\u2013957 (1997).","DOI":"10.1248\/bpb.20.954"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Samosorn S, Tanwirat B, Muhamad N, Casadei G, Tomkiewicz D, Lewis K, Suksamrarn A, Prammananan T, Gornall KC, Beck JL, Bremner JB. Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group. Bioorg. Med. Chem.<\/i>, 17<\/b>, 3866\u20133872 (2009).","DOI":"10.1016\/j.bmc.2009.04.028"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Grycov\u00e1 L, Dostal J, Marek R. Quaternary protoberberine alkaloids. Phytochemistry<\/i>, 68<\/b>, 150\u2013175 (2007).","DOI":"10.1016\/j.phytochem.2006.10.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kase Y, Hayakawa T, Aburada M, Komatsu Y, Kamataki T. Preventive effects of hange-shashin-to on irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat. Jpn. J. Pharmacol.<\/i>, 75<\/b>, 407\u2013413 (1997).","DOI":"10.1254\/jjp.75.407"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Seo MB, Lee SK, Jeon YJ, Im JS. Inhibition of p65 nuclear translocation by baicalein. Toxicol. Res.<\/i>, 27<\/b>, 71\u201376 (2011).","DOI":"10.5487\/TR.2011.27.2.071"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hsieh CJ, Hall K, Ha T, Li C, Krishnaswamy G, Chi DS. Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via<\/i> regulation of the NF-kappaB pathway. Clin. Mol. Allergy<\/i>, 5<\/b>, 5 (2007).","DOI":"10.1186\/1476-7961-5-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nakamura N, Hayasaka S, Zhang XY, Nagaki Y, Matsumoto M, Hayasaka Y, Terasawa K. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappab binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line. Exp. Eye Res.<\/i>, 77<\/b>, 195\u2013202 (2003).","DOI":"10.1016\/S0014-4835(03)00116-7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kim SO, Kundu JK, Shin YK, Park JH, Cho MH, Kim TY, Surh YJ. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene<\/i>, 24<\/b>, 2558\u20132567 (2005).","DOI":"10.1038\/sj.onc.1208446"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Li XH, McGrath KC, Tran VH, Li YM, Duke CC, Roufogalis BD, Heather AK. Attenuation of proinflammatory responses by S<\/i>-[6]-gingerol via<\/i> inhibition of ROS\/NF-kappaB\/COX2 activation in HuH7 cells. Evid. Based Complement. Alternat. Med.<\/i>, 2013<\/b>, 146142 (2013).","DOI":"10.1155\/2013\/146142"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Li Y, Xu B, Xu M, Chen D, Xiong Y, Lian M, Sun Y, Tang Z, Wang L, Jiang C, Lin Y. 6-Gingerol protects intestinal barrier from ischemia\/reperfusion-induced damage via<\/i> inhibition of p38 MAPK to NF-kappaB signalling. Pharmacol. Res.<\/i>, 119<\/b>, 137\u2013148 (2017).","DOI":"10.1016\/j.phrs.2017.01.026"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Yasuda M, Kato S, Yamanaka N, Iimori M, Utsumi D, Kitahara Y, Iwata K, Matsuno K, Amagase K, Yabe-Nishimura C, Takeuchi K. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Am. J. Physiol. Gastrointest. Liver Physiol.<\/i>, 302<\/b>, G1133\u2013G1142 (2012).","DOI":"10.1152\/ajpgi.00535.2011"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Yasuda M, Kato S, Yamanaka N, Iimori M, Matsumoto K, Utsumi D, Kitahara Y, Amagase K, Horie S, Takeuchi K. 5-HT(3) receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells. Br. J. Pharmacol.<\/i>, 168<\/b>, 1388\u20131400 (2013).","DOI":"10.1111\/bph.12019"},{"key":"34","unstructured":"34) Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer<\/i>, 3<\/b>, 330\u2013338 (2003)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Vincenzi B, Schiavon G, Pantano F, Santini D, Tonini G. Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer. Nat. Clin. Pract. Oncol.<\/i>, 5<\/b>, 455\u2013465 (2008).","DOI":"10.1038\/ncponc1137"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/12\/40_b17-00479\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T05:38:23Z","timestamp":1570426703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/12\/40_b17-00479\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00479","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}